Adjuvant low-dose aspirin does not improve unselected stage III colorectal cancer outcomes

medpagetoday.com·Jun 2, 2026 · 3 g fa

Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries

medpagetoday.com·May 30, 2026 · 6 g fa

Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages

endpoints.news·May 31, 2026 · 5 g fa

Summit, Akeso drug reduces death by 34% in China lung cancer study. Here’s what it means

medpagetoday.com·May 30, 2026 · 6 g fa

No Survival Dip After Skipping Axillary Surgery for Locally Advanced Breast Cancer

morningstar.com·May 30, 2026 · 6 g fa

Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026

endpoints.news·Jun 2, 2026 · 3 g fa

What’s next for VEGF? ASCO offered clues, but answers will have to wait

medpagetoday.com·Jun 1, 2026 · 4 g fa

Non-Operative Treatment for CRC May Include Observation After Complete Response

statnews.com·May 31, 2026 · 5 g fa

Ultra-low doses could bring costly cancer treatments to more patients in poorer countries

thenextweb.com·Jun 1, 2026 · 4 g fa

Akeso lung cancer drug cuts death risk 34% in landmark trial

cnbc.com·May 31, 2026 · 5 g fa

A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China